Reproductive Medicine

SARS-CoV-2 Identified in Semen of Men With COVID-19

Publish Date May 12, 2020

SARS-CoV-2 present in 26.7% at acute stage of infection, 8.7% of recovering patients.

SARS-CoV-2 Not Detected in Semen After COVID-19 Recovery

Publish Date April 27, 2020

At one month after COVID-19 diagnosis, SARS-CoV-2 not detected in seminal fluid.

Antioxidant Supplements Offer No Benefit in Male Infertility

Publish Date March 6, 2020

Semen quality, pregnancy or eventual live birth rates did not improve after supplement use by men.

Healthy Dietary Patterns Linked to Better Semen Quality

Publish Date February 26, 2020

Higher sperm counts found with adherence to prudent, vegetarian-like, open-sandwich versus Western pattern.

Fish Oil Supplement Intake Linked to Better Testicular Function

Publish Date January 21, 2020

Findings from cohort of young Danish men show supplement linked to higher semen volume, testicular size.

Folic Acid, Zinc Supplements in Men No Benefit in Infertility

Publish Date January 10, 2020

No significant improvement seen in semen quality, live births among couples seeking infertility treatment.

End-Stage Renal Disease Patients at Higher Risk for Syphilis

Publish Date December 2, 2019

Study shows incidence rate 3 times higher than that seen in general population.

Opioids Likely Unnecessary for Post-Vasectomy Pain

Publish Date October 15, 2019

In a study, withholding opioids after vasectomy did not increase subsequent medical encounters for scrotal pain.

Prostate Cancer Risk May Be Increased in Fathers Using Assisted Reproduction

Publish Date September 26, 2019

In a study, fathers who used intra-cytoplasmic sperm injection or in vitro fertilization had higher risk for prostate cancer than men who conceived naturally.

Selective Estrogen Receptor Modulators May Be Effective for Male Infertility

Publish Date May 29, 2019

Selective estrogen receptor modulators (SERMs) may be effective for treating male infertility, according to a recent systematic review and meta-analysis published in Expert Opinion on Pharmacotherapy. SERMs are compounds that exhibit tissue-selective estrogen receptor agonist and antagonist activity. Clomiphene citrate and tamoxifen are two agents commonly used for the off-label management of male infertility. To…